However, studies indicated that the deficiency of NAD played a role in aged NAFLD [24,25], and the high expression of NAMPT promoted the biosynthesis of NAD and indirectly reduced the risk of NASH by stimulating Sirt1/SREBP1 signaling pathway probably [26]. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.